SCHEMBL1635303

SCHEMBL1635303

CC(C)(c1c(F)c(F)c(F)c(C(=O)O)c1C(=O)O)c1c(F)c(F)c(F)c(C(=O)O)c1C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
HTT P42858 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
GLRA3 O75311 1/20 0.32
GLRB P48167 1/20 0.32
RECQL P46063 1/20 0.32
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
TAS1R3 Q7RTX0 3/20 0.31
TAS1R1 Q7RTX1 3/20 0.31
TAS1R2 Q8TE23 3/20 0.31
GAA P10253 1/20 0.31
TSHR P16473 1/20 0.30
GFER P55789 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30777257 1.00 MEN1 (0.36) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
SCHEMBL29671481 0.89 MEN1 (0.33) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
SCHEMBL7863497 0.80 GLRA3 (0.38) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
SCHEMBL11930064 0.78 GLRA3 (0.36) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
SCHEMBL29449985 0.78 CES2 (0.43) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
SCHEMBL336394 0.78 CES2 (0.43) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
SCHEMBL11930063 0.77 GLRA3 (0.39) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
Ammonia Solution, Strong SCHEMBL10455117 0.75 CES2 (0.42) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
Fluoride SCHEMBL10713010 0.75 CES2 (0.42) MEN1KMT2ASMN1; SMN2CRHBPCRHR2
SCHEMBL10454071 0.75 CES2 (0.42) MEN1KMT2ASMN1; SMN2CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9791745-B2 Photoalignment polyimide copolymer and liquid crystal alignment layer LG CHEM, LTD. (KR) 2017-10-17 US claimed
US-20140072730-A1 Photoalignment Polyimide Copolymer and Liquid Crystal Alignment Layer LG CHEM, LTD. (KR) 2014-03-13 US claimed
EP-0624826-B1 Method of forming relief patterns by i-line light irradiation OCG MICROELECTRONIC MATERIALS (US) 1997-07-16 EP claimed
EP-0624826-A1 Method of forming relief patterns by i-line light irradiation OCG Microelectronic Materials Inc. (US) 1994-11-17 EP claimed
US-9791745-B2 Photoalignment polyimide copolymer and liquid crystal alignment layer LG CHEM, LTD. (KR) 2017-10-17 US disclosed
US-8703901-B2 Transparent, highly heat-resistant polyimide precursor and photosensitive polyimide composition thereof LG CHEM, LTD. (KR) 2014-04-22 US disclosed
US-20140072730-A1 Photoalignment Polyimide Copolymer and Liquid Crystal Alignment Layer LG CHEM, LTD. (KR) 2014-03-13 US disclosed
EP-1783158-B1 FLUORINE-CONTAINING POLYMERIZABLE MONOMER AND POLYMER COMPOUND USING SAME CENTRAL GLASS CO LTD (JP) 2013-12-11 EP disclosed
US-8487069-B2 Liquid crystal photo-alignment agent, liquid crystal photo-alignment layer manufactured using the same, and liquid crystal display device including the liquid crystal photo-alignment layer CHEIL INDUSTRIES INC. (KR) 2013-07-16 US disclosed
US-20130085237-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2013-04-04 US disclosed
US-20120315498-A1 LAMINATE STRUCTURE, METHOD FOR MANUFACTUING LAMINATE STRUCTURE, ELECTRONIC ELEMENT ARRAY, IMAGE DISPLAYING MEDIUM, IMAGE DISPLAYING APPARATUS, DIAMINE, POLYAMIC ACID, AND POLYIMIDE RICOH COMPANY, LTD. (JP) 2012-12-13 US disclosed
EP-2533317-A2 Laminate structure, method for manufacturing a laminate structure, electronic element array, image displaying medium, image displaying apparatus, diamine, polyamic acid, and polyimide Ricoh Company, Ltd. (JP) 2012-12-12 EP disclosed
EP-0659800-B1 Polyimide precursor composition, polyimide composition and process for the production of said polyimide composition CENTRAL GLASS CO LTD (JP) 1999-06-23 EP disclosed
US-5840369-A SCREEN PRINTING POLYIMIDE PRECURSOR INK ON SUBSTRATE, REMOVING SOLVENT, THERMALLY CURING INK TO FORM POLYIMIDE RELIEF PATTERN FILM CENTRAL GLASS CO., LTD. (JP) 1998-11-24 US disclosed
US-5810912-A Composite hollow filamentary film of porous ceramics and process for producing the same NOK CORPORATION (JP) 1998-09-22 US disclosed
US-5686525-A THIXOTROPIC SCREEN PRINTING INK COMPRISING A HEAT TREATED POLYAMIC ACID SOLUTION OBTAINED BY REACTION OF AROMATIC TETRACARBOXYLIC ACID, DIAMINE AND A MALEIMIDE; RELIEF IMAGES CENTRAL GLASS COMPANY, LTD. (JP) 1997-11-11 US disclosed
EP-0624826-B1 Method of forming relief patterns by i-line light irradiation OCG MICROELECTRONIC MATERIALS (US) 1997-07-16 EP disclosed
US-5478918-A Low stress polyimide composition and precursor composition solution of same CENTRAL GLASS COMPANY, LIMITED (JP) 1995-12-26 US disclosed
EP-0659800-A1 Polyimide precursor composition, polyimide composition and process for the production of said polyimide composition CENTRAL GLASS COMPANY, LIMITED (JP) 1995-06-28 EP disclosed
EP-0624826-A1 Method of forming relief patterns by i-line light irradiation OCG Microelectronic Materials Inc. (US) 1994-11-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120315498-A1 LAMINATE STRUCTURE, METHOD FOR MANUFACTUING LAMINATE STRUCTURE, ELECTRONIC ELEMENT ARRAY, IMAGE DISPLAYING MEDIUM, IMAGE DISPLAYING APPARATUS, DIAMINE, POLYAMIC ACID, AND POLYIMIDE PARG, PUF60, PADI1 MEN1 349/4885KMT2A 733/4885SMN1; SMN2 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.